Barclays Maintains an 'Equalweight' on Corporate Executive Board (EXBD); Raise PT to $45; Recovery Priced In

May 4, 2011 1:47 PM EDT
Get Alerts EXBD Hot Sheet
Price: $46.25 +1.07%

Rating Summary:
    0 Buy, 0 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Barclays maintains an 'Equalweight' on Corporate Executive Board (NASDAQ: EXBD), raises PT from $39 to $45.

Barclays analyst says, "We are leaving our 2011 EPS estimate unchanged at $1.54 (+10% y/y), but raising our 2012 EPS estimate by $0.04 to $1.81 (+18% y/y). We are also shifting our price target methodology to 2012 estimates, and accordingly raising our price target by $6 to $45, which is based on 25x and 16.5x our CY'12 EPS and free cash flow estimates of $1.81 and $2.70."

For more ratings news on Corporate Executive Board click here and for the rating history of Corporate Executive Board click here.

Shares of Corporate Executive Board closed at $29.54 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments

Related Entities

Barclays